Cyklokapron 250mg

Description

Discover Cyklokapron, or Tranexamic Acid, muscle-building effects and get shredded.

The bleedings or risk of bleedings on a background of strengthening of fibrinolysis (malignant new growths of pancreas and prostate glands, operations on organs of a thorax, postnatal bleedings, manual removal of afterbirth, leucosis, diseases of the liver, previous therapy by streptokinase – cases of generalized fibrinolysis; uterus, nasal, gastroenteric bleedings, hematuria, bleedings after prostatectomy, conization of the cervix in the occasion of carcinoma, extraction of a tooth at patients with hemorrhagic diathesis – cases of local fibrinolysis).

Hereditary angioedema, allergic diseases (eczema, allergic dermatitis, nettle-rash, a medicinal and toxic rash), inflammatory diseases (tonsillitis, pharyngitis, laryngitis, stomatitis, aphthae of the mucous membrane of an oral cavity).

Collateral action of the Cyklokapron

• A rash;
• A skin itch, and other displays of the raised sensitivity of a preparation;
• Decrease in appetite;
• Nausea;
• Diarrhea;
• Heartburn;
• Drowsiness;
• Infringement of color sight.

Contraindications

The raised sensitivity to Cyklokapron preparation. With care apply at patients with thrombohemorrhagic complications (in a combination with heparin and indirect anticoagulants) and at patients with thromboses (a thrombosis of vessels of a brain, a heart attack of a myocardium, thrombophlebitis) or with a threat of their development.

Cyklokapron Special instructions

At renal insufficiency (depending on a degree of increase of creatinine of serum) reduce a dose of Cyklokapron and frequency rate of introduction. During and after treatment within several days supervision of the ophthalmologist with a:

• Check of acuteness, fields, and color sight;
• Survey of an eye bottom is necessary.

With care apply in a combination with fabric hemostatic preparations, hemocoagulase (in greater doses), heparin. At treatment of hematuria of renal genesis the risk of mechanical anger as a result of the formation of a clot in the urethra increases.